Elle Crofton always dreamed of becoming a mother. That aspiration faced a daunting challenge when she was diagnosed with myelodysplastic syndrome (MDS) at age 25. The treatment needed to combat the rare bone marrow disorder threatened to induce early menopause, potentially ending her chances of having a biological child. But thanks to specialized care at UT MD Anderson Cancer Center, Crofton is now cancer-free and a mother to a five-week-old son.
Crofton’s journey began with unexplained exhaustion, initially dismissed as a result of a busy lifestyle opening a preschool. A routine blood test revealed severely low red blood cell counts, prompting a bone marrow biopsy that confirmed the MDS diagnosis. Initially, she wasn’t overly concerned, as she’d been told MDS was often a precursor to leukemia, not cancer in itself. However, her mother’s research quickly revealed the seriousness of the condition and led them to seek a second opinion from Dr. Guillermo Garcia-Manero at UT MD Anderson, a leading expert in the field.
Finding Expertise at UT MD Anderson
Dr. Garcia-Manero, recognizing the rarity of MDS in young adults – it typically affects men over 65 – immediately recommended treatment with lenalidomide, an immunotherapy drug. He likewise initiated testing for a potential allogeneic stem cell transplant, a more aggressive treatment option requiring a donor match. This realization marked a turning point, signaling the gravity of her condition. UT MD Anderson has become a recognized center for treating complex blood cancers like MDS.
Preserving Fertility Through Oncofertility Consultation
Aware of the potential impact of a stem cell transplant – which involves strong chemotherapy – on her future fertility, Crofton proactively sought guidance from an oncofertility specialist. Dr. Terri Woodard at UT MD Anderson provided a compassionate and informative consultation, outlining the available options and their respective chances of success. UT MD Anderson’s Oncofertility Clinic offers comprehensive services to assist patients preserve their reproductive options before, during, and after cancer treatment.
Crofton opted to freeze her eggs, a decision she is profoundly grateful for. She was able to complete one cycle of egg retrieval before a suitable donor was found through the national bone marrow registry. The stem cell transplant, performed in May 2015, was successful, and she has remained in full remission ever since.
Gratitude and a Recent Chapter
Now considered a cancer survivor, Crofton no longer requires regular visits to UT MD Anderson, only routine check-ups with her primary care physician. However, the profound impact of Dr. Woodard’s care resonated deeply. She felt compelled to invite Dr. Woodard to her baby shower, wanting to share the joy of motherhood with the woman who played such a pivotal role in making it possible. “Dr. Woodard is the reason my son exists,” Crofton shared, expressing immense gratitude for the compassionate and expert care she received.
This story highlights the growing field of oncofertility and the importance of proactive fertility preservation options for individuals facing cancer treatment. Understanding what to expect during an oncofertility consultation can empower patients to make informed decisions about their future.
As Crofton embraces motherhood, her story serves as a beacon of hope for others facing similar challenges, demonstrating that cancer treatment and family building are not mutually exclusive.
Disclaimer: This article provides informational content about medical topics and should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any health condition.
Share your thoughts and experiences in the comments below. If you found this story helpful, please share it with your network.
